Diagnosing and managing invasive meningococcal disease in children
Art & Science Previous     Next

Diagnosing and managing invasive meningococcal disease in children

Camelia Laura Vaina Specialty doctor in paediatrics, Yeovil District Hospital NHS Foundation Trust, Somerset
Siba Prosad Paul Specialty trainee, year 6, in paediatric gastroenterology, Bristol Royal Hospital for Children
Anthony Paul Heaton Consultant paediatrician, Yeovil District Hospital NHS Foundation Trust, Somerset
Christine Routley Matron in paediatrics, Yeovil District Hospital NHS Foundation Trust, Somerset
Huma Mazhar Specialty trainee, year 6, in paediatrics, Yeovil District Hospital NHS Foundation Trust, Somerset

Camelia Laura Vaina and colleagues discuss a clinical audit of emergency practitioners’ adherence to guidelines for the treatment of this serious bacterial condition

In developed countries, invasive meningococcal disease (IMD) is a leading infectious cause of death among children. In the UK, Neisseria meningitidis serogroup B is the most frequently identified cause of IMD. This article describes a clinical audit in which early management of IMD is compared with recommendations in the relevant guidelines. It confirms the importance of early recognition of IMD and the need to review previous, less serious diagnoses in ill children. Emergency department nurses play a vital role in the early recognition and management of IMD. Introduction of a meningococcal B vaccine is likely to benefit children in the UK.

Emergency Nurse. 21, 2,24-27. doi: 10.7748/en2013.05.21.2.24.e1168

Correspondence

siba.paul@nhs.net

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Accepted: 15 April 2013